Contact: Karen Kreeger
University of Pennsylvania School of Medicine
Caption: This is a scheme for generating induced pluripotent stem (iPS) cells from pancreatic cancer (PDAC) and using the PDAC-iPS cells to recapitulate cancer progression and early marker discovery.
Credit: Kenneth Zaret, PhD, Perelman School of Medicine, University of Pennsylvania
Usage Restrictions: None
Related news release: Pluripotent cells from pancreatic cancer cells first human model of cancer's progression